Takeda Pharmaceutical Company Limited Gains Losses On Cash Flow Hedges Before Tax
Takeda Pharmaceutical Company Limited (TAK) reported Gains Losses On Cash Flow Hedges Before Tax of JPY 3.63 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Income Statement › Other Income
ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax · last filed 2025-06-25
| Period end | Gains Losses On Cash Flow Hedges Before Tax 12 month |
|---|---|
| 2025-03-31 | 3.63B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 171.06B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 56.44B JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | 82.78B JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | -40.83B JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | -37.63B JPY 20-F · filed 2022-06-29 |
| 2019-03-31 | -28.06B JPY 20-F · filed 2021-06-29 |
| 2018-03-31 | -1.46B JPY 20-F · filed 2020-06-24 |
| 2017-03-31 | 7.25B JPY 20-F · filed 2019-06-27 |